Scott J. Charles, Chief Financial Officer at Aralez Pharmaceuticals Inc. (ARLZ), sold 5,205 shares at $2.41 ($13K) on 2017-03-20, disclosed to the SEC on 2017-03-22.
Scheduled sale ($13k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |